Hans Schreiber

Affiliations: 
University of Chicago, Chicago, IL 
Area:
Pathology, Oncology, Cell Biology
Google:
"Hans Schreiber"

Children

Sign in to add trainee
Terry H. Wu grad student 2001 Chicago
Michael T. Spiotto grad student 2003 Chicago
David C. Binder grad student 2013 Chicago
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shin SC, Vickman RE, Filimon B, et al. (2024) The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer Gene Therapy
Wolf SP, Anastasopoulou V, Drousch K, et al. (2024) One CD4+TCR and one CD8+TCR targeting autochthonous neoantigens are essential and sufficient for tumor eradication. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Xu W, Shin SC, Vickman R, et al. (2023) The Safety and Efficacy of Systemic Delivery of a New Liver-de-targeted TGFβ Signaling Inhibiting Adenovirus in an Immunocompetent Triple Negative Mouse Mammary Tumor Model. Research Square
Ranoa DRE, Sharma P, Schane CP, et al. (2023) Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model. Journal For Immunotherapy of Cancer. 11
Hu Y, Cao G, Chen X, et al. (2021) Antigen-Multimers: Specific, Sensitive, Precise, and Multifunctional High-Avidity CAR-Staining Reagents. Matter. 4: 3917-3940
Wolf SP, Wen FT, Schreiber H. (2021) Criteria to make animal studies more relevant to treating human cancer. Current Opinion in Immunology. 74: 25-31
Sharma P, Marada VVVR, Cai Q, et al. (2020) Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides. Proceedings of the National Academy of Sciences of the United States of America
Diehl MI, Wolf SP, Bindokas VP, et al. (2020) Automated cell cluster analysis provides insight into multi-cell-type interactions between immune cells and their targets. Experimental Cell Research. 112014
Seth P, Xu W, Yang Y, et al. (2020) LyP-1-modified oncolytic adenoviruses targeting transforming growth factor β inhibit tumor growth and metastases and augment immune checkpoint inhibitor therapy in breast cancer mouse models. Human Gene Therapy
Böttinger P, Schreiber K, Hyjek E, et al. (2020) Cooperation of genes in HPV16 E6/E7-dependent cervico-vaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens. Carcinogenesis
See more...